JPRN-jRCT2080220845
Unknown
Phase 3
Phase III Clinical Study of Intravenous Administration of S-021812 in Pediatric Patients with Influenza Virus Infection
ConditionsInfluenza virus infection
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Influenza virus infection
- Sponsor
- SHIONOGI & CO., LTD.
- Enrollment
- 100
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pediatric patient diagnosed as influenza virus infection
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A Phase-I clinical study of intravenous AntiPlatelet, AntiCoagulant (APAC) in healthy subjects.CTRI/2023/04/051500Cadila Pharmaceutical Limited
Not yet recruiting
Phase 1
Mesenchymal Stem Cell Therapy For Covid 19Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/08/027043eurogen Brain and Spine Institute
Active, not recruiting
Phase 1
Trial to test the safety, half-life, and antiviral efficacy of a new drug (human antibody) called DZIF-10c (administered intravenously) in healthy volunteers and SARS-CoV-2-infected participantsSARS-CoV-2 infection (only mild to moderate disease)MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-003503-34-DEniversity of Cologne69
Completed
Phase 3
A Phase III Clinical Trial of Intra-arterial TheraSphere® in the Treatment of Patients with Unresectable Hepatocellular Carcinoma (HCC).hepatocellular carcinomaliver cancer10019815NL-OMON50334Biocompatibles UK Ltd.38
Completed
Not Applicable
A randomised phase III study of intravenous (i.v.) zoledronate (administered for 12 versus 36 months) as an adjunct to standard therapies in the treatment of multiple myelomaMultiple myelomaCancerMultiple myeloma and malignant plasma cell neoplasmsISRCTN23172547Dutch Haemato-Oncology Association (Stichting Hemato-Oncologie Volwassenen Nederland) (HOVON) (Netherlands)407